By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Life and health insurance firm Aetna will fund a collaborative effort involving Georgetown University, the University of South Florida, and the American Cancer Society that will study how genetic tests for breast cancer are used for certain groups of women, and whether some women are getting tested unnecessarily while others lack access to such services.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.